Abstract
Background
Obesity is frequently associated to many functional gastrointestinal disorders. The aim of the present study was to assess the prevalence of functional gastrointestinal disorders in obese patients, according to their body mass index and their recruitment source.
Methods
Five hundred ninety-six obese patients (body mass index (BMI) > 30) filled out a standard questionnaire in order to evaluate the presence of functional gastrointestinal disorders. They were divided into four groups according to the Rome III criteria and their BMI: OF, obese patients from functional gastrointestinal disorder (FGID) enrollment; OO, obese patients from obesity management enrollment; MF, morbid obesity patients from FGID enrollment; and MO, morbid obesity patients from obesity management enrollment. Data analysis was performed using multivariate logistic regression.
Results
Out of the 596 obese patients included in the present study, 183 (33 %) were complaining of FGIDs, while 413 (67 %) were consulting for obesity management. Compared to the OF group, the OO patients had a higher prevalence of females (P = 0.008) and a younger age (P < 0.001). Clinically, they reported a lower incidence of regurgitation (P = 0.044), of chest pain (P = 0.004), of irritable bowel syndrome (IBS; P = 0.035), and of functional diarrhea (P = 0.030). Compared to the MF group, the MO patients had an older age (P = 0.001), a higher BMI (P = 0.013), and clinically by a high frequency of functional dyspepsia (P = 0.006). There were symptoms that had similar prevalence in all groups (OF, OO, MF, MO) such as epigastric pain, postprandial distress, constipation, diarrhea, bloating, abdominal pain soiling, or nonspecific anorectal disorders.
Conclusions
This study has shown that the recruitment source accounted for marked and specific differences in the prevalence of functional gastrointestinal disorders in obesity and morbid obesity. Symptoms with similar prevalence in all groups should be systematically detected in all patients.
Similar content being viewed by others
References
World Health Organization W. Obesity and overweight. Geneva (Switzerland): World Health Organization; 2013 [cited 2013 March]; Available from: http://www.who.int/mediacentre/factsheets/fs311/en/.
Centers for Disease Control and Prevention C. Adult overweight and obesity. Atlanta, USA: Centers for Disease Control and Prevention; 2013; Available from: http://www.cdc.gov/obesity/adult/index.html.
INSERM, editor. ObEpi-Roche 2012: enquête nationale sur l’obésité et le surpoids. 6 ed: INSERM/KANTAR HEALTH/ROCHE; 2013.
Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999–2010. JAMA. 2012;307(5):491–7.
Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer- and service-specific estimates. Health Aff (Millwood). 2009;28(5):w822–31.
Galmiche JP, Clouse RE, Balint A, Cook IJ, Kahrilas PJ, Paterson WG, et al. Functional esophageal disorders. Gastroenterology. 2006;130(5):1459–65.
Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, et al. Functional gastroduodenal disorders. Gastroenterology. 2006;130(5):1466–79.
Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130(5):1480–91.
Clouse RE, Mayer EA, Aziz Q, Drossman DA, Dumitrascu DL, Monnikes H, et al. Functional abdominal pain syndrome. Gastroenterology. 2006;130(5):1492–7.
Bharucha AE, Wald A, Enck P, Rao S. Functional anorectal disorders. Gastroenterology. 2006;130(5):1510–8.
Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006;130(5):1377–90.
Talley NJ, Zinsmeister AR, Melton 3rd LJ. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol. 1995;142(1):76–83.
Clements RH, Gonzalez QH, Foster A, Richards WO, McDowell J, Bondora A, et al. Gastrointestinal symptoms are more intense in morbidly obese patients and are improved with laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2003;13(4):610–4.
Talley NJ, Howell S, Poulton R. Obesity and chronic gastrointestinal tract symptoms in young adults: a birth cohort study. Am J Gastroenterol. 2004;99(9):1807–14.
Delgado-Aros S, Locke 3rd GR, Camilleri M, Talley NJ, Fett S, Zinsmeister AR, et al. Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol. 2004;99(9):1801–6.
Mathus-Vliegen EM, Tygat GN. Gastro-oesophageal reflux in obese subjects: influence of overweight, weight loss and chronic gastric balloon distension. Scand J Gastroenterol. 2002;37(11):1246–52.
Levy RL, Linde JA, Feld KA, Crowell MD, Jeffery RW. The association of gastrointestinal symptoms with weight, diet, and exercise in weight-loss program participants. Clin Gastroenterol Hepatol. 2005;3(10):992–6.
Talley NJ, Quan C, Jones MP, Horowitz M. Association of upper and lower gastrointestinal tract symptoms with body mass index in an Australian cohort. Neurogastroenterol Motil. 2004;16(4):413–9.
Vakil N. Body mass index and gastroesophageal reflux disease: implications of the obesity epidemic. Dig Dis Sci. 2008;53(9):2291–2.
Fysekidis M, Bouchoucha M, Bihan H, Reach G, Benamouzig R, Catheline JM. Prevalence and co-occurrence of upper and lower functional gastrointestinal symptoms in patients eligible for bariatric surgery. Obes Surg. 2012;22(3):403–10.
Bouchoucha M, Fysekidis M, Catheline J-M, Airinei G, Reach G, Aparicio T, et al., editors. Modification de la symptomatologie fonctionnelle digestive des patients souffrant d’obésité morbide après chirurgie bariatrique Journées Francophones d’Hépato-gastroentérologie et d’oncologie Digestive; 2014; Paris.
Bouchoucha M, Devroede G, Arsac M. Anismus: a marker of multi-site functional disorders? Int J Colorectal Dis. 2004;19(4):374–9.
Locke 3rd GR, Talley NJ, Fett SL, Zinsmeister AR, Melton 3rd LJ. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med. 1999;106(6):642–9.
Nilsson M, Johnsen R, Ye W, Hveem K, Lagergren J. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA. 2003;290(1):66–72.
Dutta SK, Arora M, Kireet A, Bashandy H, Gandsas A. Upper gastrointestinal symptoms and associated disorders in morbidly obese patients: a prospective study. Dig Dis Sci. 2009;54(6):1243–6.
Andersen LI, Jensen G. Risk factors for benign oesophageal disease in a random population sample. J Intern Med. 1991;230(1):5–10.
Zalar A, Haddouche B, Antonietti M, Alhameedi R, Iwanicki-Caron I, Lecleire S, et al. Lack of correlation between morbid obesity and severe gastroesophageal reflux disease in candidates for bariatric surgery: results of a large prospective study. Obes Surg. 2013;23(11):1939–41.
Swartz DE, Mobley E, Felix EL. Bile reflux after Roux-en-Y gastric bypass: an unrecognized cause of postoperative pain. Surg Obes Relat Dis. 2009;5(1):27–30.
Cremonini F, Locke 3rd GR, Schleck CD, Zinsmeister AR, Talley NJ. Relationship between upper gastrointestinal symptoms and changes in body weight in a population-based cohort. Neurogastroenterol Motil. 2006;18(11):987–94.
Lopez-Alvarenga JC, Vargas JA, Lopez LH, Fass R, Sobrino-Cossio S, Higgins P, et al. Effect of body weight and esophageal damage on the severity of gastroesophageal reflux symptoms. Mexican GERD working group. Arch Med Res. 2009;40(7):576–81.
Le Pluart D, Sabaté JM, Bouchoucha M, Hercberg S, Benamouzig R, Julia C. Functional gastrointestinal disorders in 35,447 adults and their association with body mass index. Aliment Pharmacol Ther. 2015;In Press.
Cremonini F, Camilleri M, Clark MM, Beebe TJ, Locke GR, Zinsmeister AR, et al. Associations among binge eating behavior patterns and gastrointestinal symptoms: a population-based study. Int J Obes (Lond). 2009;33(3):342–53.
Santonicola A, Angrisani L, Ciacci C, Iovino P. Prevalence of functional gastrointestinal disorders according to Rome III criteria in Italian morbidly obese patients. ScientificWorldJournal. 2013;2013:532503.
Aslam M, Slaughter JC, Goutte M, Garrett CG, Hagaman D, Vaezi MF. Nonlinear relationship between body mass index and esophageal acid exposure in the extraesophageal manifestations of reflux. Clin Gastroenterol Hepatol. 2012;10(8):874–8.
Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143(3):199–211.
Corley DA, Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Gastroenterol. 2006;101(11):2619–28.
Jacobson BC, Schroy 3rd PC. The skinny on obesity and reflux. Gastroenterology. 2006;130(6):1925–6.
El-Serag H. The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci. 2008;53(9):2307–12.
Greer WJ, Richter HE, Bartolucci AA, Burgio KL. Obesity and pelvic floor disorders: a systematic review. Obstet Gynecol. 2008;112(2 Pt 1):341–9.
Eslick GD. Gastrointestinal symptoms and obesity: a meta-analysis. Obes Rev. 2012;13(5):469–79.
Statements
ᅟ
Contributorship
MB performed the research, contributed to the design of the study, revised the article content, and finally approved the version to be published.
MF interpreted the data, drafted the article, revised the article content, and finally approved the version to be published.
CJ interpreted the data.
GA participated in the selection of patients and the design of the study.
JMC, GR, and RB contributed to the design of the study, revised the article content, and finally approved the version to be published.
Funding
No funding
Conflict of Interest Statement
All authors declare that they do not have any conflict of interest regarding this paper.
Ethical Approval
For this study, formal consent is not required.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Role of the Funding Source
No funding sources had any role in study design, collection, analysis, and interpretation of data or writing of the report. The corresponding author had full access to all the data of the study and had final responsibility for the decision to submit it for publication.
Financial Disclosure
None of the authors have any financial interest to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bouchoucha, M., Fysekidis, M., Julia, C. et al. Functional Gastrointestinal Disorders in Obese Patients. The Importance of the Enrollment Source. OBES SURG 25, 2143–2152 (2015). https://doi.org/10.1007/s11695-015-1679-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-015-1679-6